Brachytherapy for vaginal cancer is highly individualized.
This small case series included stage I–II patients with limited tumor volume.
A pelvic MRI with vaginal cylinder in place (MRVC) documented tumor extent at diagnosis.
Patients with initial tumor thickness on MRVC ≤ 2 cm received EBRT + intra-cavitary boost.
Best results were among those with no residual disease at time of brachytherapy.